90 related articles for article (PubMed ID: 18056464)
1. Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.
Ruhe JE; Streit S; Hart S; Wong CH; Specht K; Knyazev P; Knyazeva T; Tay LS; Loo HL; Foo P; Wong W; Pok S; Lim SJ; Ong H; Luo M; Ho HK; Peng K; Lee TC; Bezler M; Mann C; Gaertner S; Hoefler H; Iacobelli S; Peter S; Tay A; Brenner S; Venkatesh B; Ullrich A
Cancer Res; 2007 Dec; 67(23):11368-76. PubMed ID: 18056464
[TBL] [Abstract][Full Text] [Related]
2. Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
Son MY; Kim J; Han HW; Woo SM; Cho YS; Kang YK; Han YM
Reproduction; 2008 Oct; 136(4):423-32. PubMed ID: 18583472
[TBL] [Abstract][Full Text] [Related]
3. Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.
Mendes KN; Nicorici D; Cogdell D; Tabus I; Yli-Harja O; Guerra R; Hamilton SR; Zhang W
J Proteome Res; 2007 Jul; 6(7):2753-67. PubMed ID: 17564428
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
5. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
[TBL] [Abstract][Full Text] [Related]
6. Kinome profiling in pediatric brain tumors as a new approach for target discovery.
Sikkema AH; Diks SH; den Dunnen WF; ter Elst A; Scherpen FJ; Hoving EW; Ruijtenbeek R; Boender PJ; de Wijn R; Kamps WA; Peppelenbosch MP; de Bont ES
Cancer Res; 2009 Jul; 69(14):5987-95. PubMed ID: 19567681
[TBL] [Abstract][Full Text] [Related]
7. The role of Shp2 (PTPN11) in cancer.
Mohi MG; Neel BG
Curr Opin Genet Dev; 2007 Feb; 17(1):23-30. PubMed ID: 17227708
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
9. Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines.
Stoeger SM; Cowan KH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):807-18. PubMed ID: 18661133
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
Takeuchi K; Shin-ya T; Nishio K; Ito F
FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
[TBL] [Abstract][Full Text] [Related]
11. PTP-PEST phosphatase variations in human cancer.
Streit S; Ruhe JE; Knyazev P; Knyazeva T; Iacobelli S; Peter S; Hoefler H; Ullrich A
Cancer Genet Cytogenet; 2006 Oct; 170(1):48-53. PubMed ID: 16965954
[TBL] [Abstract][Full Text] [Related]
12. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor structural alterations in gastric cancer.
Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated mutations are preferentially distributed in protein kinase functional sites.
Izarzugaza JM; Redfern OC; Orengo CA; Valencia A
Proteins; 2009 Dec; 77(4):892-903. PubMed ID: 19626714
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.
Cheung AK; Lung HL; Hung SC; Law EW; Cheng Y; Yau WL; Bangarusamy DK; Miller LD; Liu ET; Shao JY; Kou CW; Chua D; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Cancer Res; 2008 Oct; 68(19):8137-45. PubMed ID: 18829573
[TBL] [Abstract][Full Text] [Related]
16. Mutator phenotype in cancer: timing and perspectives.
Bielas JH; Loeb LA
Environ Mol Mutagen; 2005; 45(2-3):206-13. PubMed ID: 15672382
[TBL] [Abstract][Full Text] [Related]
17. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
Kubo T; Kuroda Y; Shimizu H; Kokubu A; Okada N; Hosoda F; Arai Y; Nakamura Y; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Hirohashi S; Shibata T
Carcinogenesis; 2009 Nov; 30(11):1857-64. PubMed ID: 19734198
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays.
Kim HJ; Lin D; Lee HJ; Li M; Liebler DC
Mol Cell Proteomics; 2016 Feb; 15(2):682-91. PubMed ID: 26631510
[TBL] [Abstract][Full Text] [Related]
19. Tumor vessel up-regulation of INSR revealed by single-cell expression analysis of the tyrosine kinome and phosphatome in human cancers.
Kiflemariam S; Ljungström V; Pontén F; Sjöblom T
Am J Pathol; 2015 Jun; 185(6):1600-9. PubMed ID: 25864925
[TBL] [Abstract][Full Text] [Related]
20. Monitoring signal transduction in cancer: tyrosine kinase gene expression profiling.
Weier HU; Zitzelsberger HF; Hsieh HB; Sun MV; Wong M; Lersch RA; Yaswen P; Smida J; Kuschnick C; Clark OH
J Histochem Cytochem; 2001 May; 49(5):673-4. PubMed ID: 11304810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
